Patent Act (R.S.C., 1985, c. P-4)

Act current to 2014-10-27 and last amended on 2013-06-26. Previous Versions

Marginal note:Report
  •  (1) The Board shall in each year submit to the Minister a report setting out

    • (a) the Board’s estimate of the proportion, as a percentage, that the expenditures of each patentee in Canada in the preceding year on research and development relating to medicine is of the revenues of those patentees from sales of medicine in Canada in that year; and

    • (b) the Board’s estimate of the proportion, as a percentage, that the total of the expenditures of patentees in Canada in the preceding year on research and development relating to medicine is of the total of the revenues of those patentees from sales of medicine in Canada in that year.

  • Marginal note:Basis of report

    (2) The report shall be based on an analysis of information and documents provided to the Board under subsections 88(1) and (2) and of such other information and documents relating to the revenues and expenditures referred to in subsection 88(1) as the Board considers relevant but, subject to subsection (3), shall not be set out in a manner that would make it possible to identify a person who provided any information or document under subsection 88(1) or (2).

  • Marginal note:Exception

    (3) The Board shall, in the report, identify the patentees in respect of whom an estimate referred to in subsection (1) is given in the report, and may, in the report, identify any person who has failed to comply with subsection 88(1) or (2) at any time in the year in respect of which the report is made.

  • Marginal note:Tabling of report

    (4) The Minister shall cause a copy of the report to be laid before each House of Parliament on any of the first thirty days on which that House is sitting after the report is submitted to the Minister.

  • 1993, c. 2, s. 7.

Inquiries

Marginal note:Inquiries

 The Board shall inquire into any matter that the Minister refers to the Board for inquiry and shall report to the Minister at the time and in accordance with the terms of reference established by the Minister.

  • 1993, c. 2, s. 7.

Patented Medicine Prices Review Board

Marginal note:Establishment
  •  (1) The Patented Medicine Prices Review Board is hereby continued, and shall consist of not more than five members to be appointed by the Governor in Council.

  • Marginal note:Tenure

    (2) Each member of the Board shall hold office during good behaviour for a period of five years, but may be removed at any time by the Governor in Council for cause.

  • Marginal note:Reappointment

    (3) A member of the Board, on the expiration of a first term of office, is eligible to be reappointed for one further term.

  • Marginal note:Acting after expiration of appointment

    (4) A person may continue to act as a member of the Board after the expiration of the person’s term of appointment in respect of any matter in which the person became engaged during the term of appointment.

  • Marginal note:Remuneration and expenses

    (5) The members of the Board shall be paid such remuneration as may be fixed by the Governor in Council and are entitled to be paid reasonable travel and living expenses incurred by them in the course of their duties under this Act while absent from their ordinary place of residence.

  • 1993, c. 2, s. 7.